MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 250 filers reported holding MEDIVATION INC in Q2 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,275,000 | -20.6% | 100,790 | -41.4% | 0.36% | -20.7% |
| Q1 2016 | $7,907,000 | -8.0% | 171,956 | -3.3% | 0.45% | +18.7% |
| Q4 2015 | $8,595,000 | -0.7% | 177,801 | -12.7% | 0.38% | -16.9% |
| Q3 2015 | $8,654,000 | -30.1% | 203,628 | +87.9% | 0.46% | -10.6% |
| Q2 2015 | $12,373,000 | -15.7% | 108,346 | -4.7% | 0.51% | -11.9% |
| Q1 2015 | $14,679,000 | +15.7% | 113,730 | -10.7% | 0.58% | +8.6% |
| Q4 2014 | $12,692,000 | -17.7% | 127,420 | -18.4% | 0.53% | -17.4% |
| Q3 2014 | $15,429,000 | -11.3% | 156,058 | -30.9% | 0.64% | -4.3% |
| Q2 2014 | $17,397,000 | +24.2% | 225,696 | +3.7% | 0.67% | +26.7% |
| Q1 2014 | $14,004,000 | -3.8% | 217,557 | -4.6% | 0.53% | +1.5% |
| Q4 2013 | $14,561,000 | -10.1% | 228,158 | -15.6% | 0.52% | -22.0% |
| Q3 2013 | $16,196,000 | – | 270,204 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |